|
Administration
Should be taken with food. Take during or immediately after meals.
|
|
Contraindications
1st trimester of pregnancy and lactation.
|
|
Special Precautions
Patient w/ current or a history of blood dyscrasias. Pregnancy (2nd and 3rd trimester). Hepatic and renal impairment. Monitoring Parameters Monitor total and differential leukocyte counts. Closely monitor childn when treatment duration exceeds 3 days.
|
|
Adverse Reactions
Transient leucopenia, ataxia, convulsions, dizziness, headache, hypesthesia, paraesthesia, peripheral neuropathy, sensory disturbances, vertigo, metallic taste, flushing, abdominal pain, anorexia, diarrhoea, furry tongue, glossitis, nausea, stomatitis, vomiting, dark urine, fever, tiredness.
Potentially Fatal: Hypersensitivity. |
|
Drug Interactions
May potentiate the effects of oral anticoagulants resulting to prolonged prothrombin time.
|
|
CIMS Class
|
|
ATC Classification
G01AF21 - tinidazole ; Belongs to the class of imidazole derivative antiinfectives. Used in the treatment of gynecological infections.
P01AB02 - tinidazole ; Belongs to the class of nitroimidazole derivatives antiprotozoals. Used in the treatment amoebiasis and other protozoal diseases. J01XD02 - tinidazole ; Belongs to the class of imidazole derivative antibacterials. Used in the systemic treatment of infections. |
Sign Out
